BEYOND MEAT, INC. (NASDAQ: BYND) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Beyond Meat, Inc. Investors of Upcoming Deadline
globenewswire.com
Want to monitor MIRM?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor MIRMMirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Mirum's lead product candidate, maralixibat, is an investigational oral drug in development for Alagille syndrome (ALGS), progressive familial intrahepatic cholestasis (PFIC), and biliary atresia.